香雪品牌怎么样 申请店铺

我要投票 香雪在中草药行业中的票数:767 更新时间:2026-01-08
香雪是哪个国家的品牌?「香雪」是 广州市香雪制药股份有限公司 旗下著名品牌。该品牌发源于广东,由创始人王永辉在1986期间创立,经过多年的不懈努力和高速发展,现已成为行业的标杆品牌。

外推网助力香雪品牌出海!将品牌入驻外推网,定制香雪品牌推广信息,可以显著提高香雪产品曝光,简直是跨境电商爆单神器!目前仅需1000元/年哦~

香雪怎么样

广州市香雪制药股份有限公司总部位于广州经济技术开发区科学城,是一家以中成药制药和研发为主业,集西药制药、生物医学工程和药材规范种植于一体的现代化高新技术医药企业。

公司秉承“厚生臻善维新”的企业理念,坚持“崇尚品质;关爱健康”的质量方针,坚持自主创新、自主品牌,在品质、技术、研发、品牌和规模等多方面成长为行业领先者,得到消费者、行业和政府主管部门的高度评价和广泛认可,其中“香雪”商标获评中国驰名商标,“香雪抗病毒口服液”获评广东省名牌和广州市名牌产品,香雪制药获评“《福布斯》中国成长企业潜力榜100强”前五位,香雪制药获评“广东省医药产业50强企业”和“广州2010年亚运会药品供应商”等。

香雪制药一直致力于质量创新,致力于中药现代化的研究和实践,1998年开始进行中药现代化关键技术指纹图谱质量控制技术的研究,并取得重大突破。2001年,香雪抗病毒口服液指纹图谱质控研究被纳入广州名优中成药品种指纹图谱质量控制示范研究项目。2000年,香雪制药本着“实施中药系列标准规范,提高中成药品种质量”的理念,承担了国家科技部的“九五”重点科技攻关项目广藿香GAP种植基地,经过一年多的探索与研究,现已被国家科技部列入第一批国家中药现代化科技产业化(广东)基地,并通过国家验收。

香雪制药本着高起点、高技术、高标准、高速度的现代企业发展战略,采用先进的技术、工艺、设备,形成了完善、科学、先进的生产体系,使公司的产品质量和主要技术指标均达到了国内先进水平。公司坚持“创新”为企业的灵魂,以科技进步推动企业的发展。近年来承担了多项国家及省、市级重大科技专项技术的研究与开发;本着生产一代、储备一代、研制一代、构思一代的新产品开发战略。加快了疗效确切、科技含量高的新产品的研制开发。

Guangzhou Xiangxue Pharmaceutical Co., Ltd., headquartered in Science City, Guangzhou Economic and Technological Development Zone, is a modern high-tech pharmaceutical enterprise with Chinese patent medicine and R & D as its main business, integrating western medicine, biomedical engineering and standard planting of medicinal materials. The company adheres to the enterprise concept of "great life, perfect and innovative", and adheres to "advocating quality"; The company adheres to the quality policy of "care for health", adheres to independent innovation and independent brand, grows into the industry leader in quality, technology, R & D, brand and scale, and is highly appraised and widely recognized by consumers, industry and government authorities. Among them, "Xiangxue" trademark is awarded the famous trademark in China, and "Xiangxue antiviral oral liquid" is awarded the famous brand in Guangdong Province and Guangzhou city Brand products, Xiangxue pharmaceutical won the top five "Forbes China growth enterprise potential list top 100", Xiangxue pharmaceutical won the "top 50 pharmaceutical enterprises in Guangdong Province" and "drug supplier of Guangzhou 2010 Asian Games" and so on. Xiangxue pharmaceutical has been committed to quality innovation, research and practice of the modernization of traditional Chinese medicine. In 1998, it began to study the key technology of the modernization of traditional Chinese medicine fingerprint quality control technology, and made a major breakthrough. In 2001, the fingerprint quality control research of Xiangxue antiviral oral liquid was included in the quality control demonstration research project of Guangzhou famous and excellent Chinese patent medicine. In 2000, in line with the concept of "implementing the standards and specifications of traditional Chinese medicine series and improving the quality of traditional Chinese medicine varieties", Xiangxue pharmaceutical undertook the patchouli gap planting base, a key scientific and technological key project of the Ninth Five Year Plan of the Ministry of science and technology of the people's Republic of China. After more than a year's exploration and research, it has been listed in the first batch of national bases for the modernization of science and technology industrialization of traditional Chinese medicine (Guangdong) by the Ministry of science and technology of the people's Republic of China and passed the national acceptance 。 Based on the modern enterprise development strategy of high starting point, high technology, high standard and high speed, Xiangxue pharmaceutical adopts advanced technology, process and equipment to form a perfect, scientific and advanced production system, so that the product quality and main technical indicators of the company have reached the advanced level in China. The company adheres to "innovation" as the soul of the enterprise and promotes the development of the enterprise with the progress of science and technology. In recent years, it has undertaken the research and development of a number of national, provincial and municipal major science and technology special technologies; in line with the new product development strategy of production generation, storage generation, development generation and conception generation. The research and development of new products with precise curative effect and high technology content are accelerated.

本文链接: https://brand.waitui.com/f0447df2d.html 联系电话:请联系客服添加 联系邮箱:请联系客服添加

外推网广告位招租,每天只要9块9

7×24h 快讯

具身机器人也有自己的保单,险企竞逐机器人保险业务

机器人租赁市场需求旺盛,也催生了大量的保险保障需求。多位业内人士认为,机器人保险作为新型保险产品,其发展成熟需要大量的数据支撑,如果仅与单一企业合作或投保单一设备,数据积累会比较慢。通过与租赁平台等合作,不仅可以获得批量保单,也有利于实现数据的快速积累,为精算定价、风险理赔提供数据支撑,机器人保险有望迎来新增长极。不过,机器人保险在我国还处在起步阶段,发展过程中的风险评估难、产品适配差、责任界定难、风控能力弱等问题,还需要多方协作、共同破局。(上证报)

2小时前

日本11月份实际工资同比下降2.8%,为去年1月以来最大降幅

日本政府周四公布的初步数据显示,受一次性奖金大幅减少的拖累,日本11月份实际工资出现了自去年1月以来的最大降幅。与此同时,通胀超过工资增长的潜在趋势没有改变,这给日本央行带来了挑战。此前日本央行已发出信号,将在今年继续加息。(新浪财经)

2小时前

机构称2026年铜市上行趋势明朗

2025年年末,国内铜现货(电解铜)价格突破100000元/吨关口,为铜市注入强劲动力。与此同时,2026年长单签订博弈进入白热化,国内提价潮、外贸溢价攀升、铜精矿加工费(TC/RC)低位僵持等现象集中出现。业内人士表示,这既反映出市场对供需格局的预判,也预示着2026年铜价或开启新一轮上涨行情。(中证网)

2小时前

中信建投:商业航天产业有望进入新纪元

36氪获悉,中信建投指出,当前商业航天产业在国家政策支持和产业技术突破共同助力下,有望进入新纪元。商业航天产业涉及信息化的主要环节包括(1)遥感及其应用;(2)卫星测运控系统;(3)CAE仿真/卫星测试;(4)星际传输处理模块、通信模组、数据处理平台等;新场景扩展层面关注太空算力。此外,我们认为当前商业航天发展是国企与民营企业共振周期。

2小时前

耐心资本布局硬科技,社保科创基金多地落子

长期资本正在重塑科技创新领域的投资生态。全国社会保障基金理事会官网显示,目前已成立的5只社保科创基金定位均为“服务国家发展的市场化基金”,旨在疏通金融资源进入实体经济的渠道,增加支持科技创新和产业创新深度融合的有效投资,在服务科技强国建设、助力科创企业成长中实现基金安全和保值增值。多位专家介绍,从浙江首发到江苏、福建、湖北、四川相继跟进,社保科创基金的迅速布局,标志着国家长期、耐心资本与区域创新战略的系统性对接已进入加速布局阶段。(上证报)

2小时前

本页详细列出关于香雪的品牌信息,含品牌所属公司介绍,香雪所处行业的品牌地位及优势。
咨询